Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 63

    IHH Healthcare extends acceptance period of enhanced revised offer for Fortis

    IHH Healthcare extends acceptance period of enhanced revised offer for Fortis

    Ruby Khatun Khatun18 May 2018 11:30 AM IST
    New Delhi: Malaysian firm IHH Healthcare Berhard said it has extended the acceptance period of its enhanced revised proposal for Fortis Healthcare to...
    Bengaluru: Illegally imported skin-whitening drugs worth Rs 13.5 lakh recovered

    Bengaluru: Illegally imported skin-whitening drugs worth Rs 13.5 lakh recovered

    Ruby Khatun Khatun17 May 2018 4:30 PM IST
    It is believed by the investigators that the drug is used for skin bleaching through unethical medical practices in cosmetology clinics and beauty...
    Orchid Pharma: Lenders reject resolution plan, Company to move to Liquidation

    Orchid Pharma: Lenders reject resolution plan, Company to move to Liquidation

    Ruby Khatun Khatun16 May 2018 12:52 PM IST
    MUMBAI: The resolution plan of the bankrupt Orchid Pharma has been rejected by the lenders of the company that might drive the firm towards...
    Manipal now offers Rs 180 per share for Fortis Healthcare

    Manipal now offers Rs 180 per share for Fortis Healthcare

    Ruby Khatun Khatun15 May 2018 11:55 AM IST
    New Delh: The Manipal-TPG combine today revised the offer for Fortis Healthcare by committing to invest in the cash-strapped firm at Rs 180 per share,...
    Indian Healthcare sector may touch Rs 8.6 Trillion by FY22: Report

    Indian Healthcare sector may touch Rs 8.6 Trillion by FY22: Report

    Medical Dialogues Bureau14 May 2018 2:10 PM IST
    The healthcare industry is expected to grow annually at 16-17 percent to reach to Rs 8.6 trillion by FY22 on the back of the Centre's Ayushman Bharat...
    Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

    Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS

    Medical Dialogues Bureau13 May 2018 11:57 AM IST
    New Delhi: Advanced, affordable and accessible solutions is the only way forward towards intensifying the innovations in Indian pharma sector,...
    Fortis Takeover Bid: IHH, Manipal-TPG disappointed With Board Decision

    Fortis Takeover Bid: IHH, Manipal-TPG disappointed With Board Decision

    Medical Dialogues Bureau12 May 2018 11:57 AM IST
    New Delhi: After losing out to Munjal-Burman combine in the race for Fortis, Malaysia's IHH Healthcare today said it is looking to speak to the...
    Invest more in RnD, develop new markets to boost pharma exports: Prabhu to industry

    Invest more in RnD, develop new markets to boost pharma exports: Prabhu to industry

    Medical Dialogues Bureau12 May 2018 10:56 AM IST
    New Delhi: Commerce and Industry Minister Suresh Prabhu today asked pharma firms to increase R&D investments and develop new markets to boost the...
    Bharat Biotech receives National Technology Award for ROTAVAC® from the President of India

    Bharat Biotech receives National Technology Award for ROTAVAC® from the President of India

    Medical Dialogues Bureau12 May 2018 10:50 AM IST
    Hyderabad: Bharat Biotech announces the receipt of the National Technology Award for 2018 from the Technology Development Board, Govt of India. This...
    Battle For Fortis: Munjal-Burmans emerge Victorious

    Battle For Fortis: Munjal-Burmans emerge Victorious

    Medical Dialogues Bureau11 May 2018 3:36 PM IST
    New Delhi: The board of Fortis Healthcare today recommended the binding offer of the Munjal-Burmans combine to the shareholders after 18 months of...
    Suven secures product patents in Australia, Eurasia and Europe

    Suven secures product patents in Australia, Eurasia and Europe

    Medical Dialogues Bureau10 May 2018 4:51 PM IST
    New Delhi: Suven Life Sciences today said it has been granted a product patent by Australia, Eurasia and Europe corresponding to a new chemical entity...
    Seized from Delhi: Prohibited drugs including Alprazolam, Diazepam Worth Rs 10 crore

    Seized from Delhi: Prohibited drugs including Alprazolam, Diazepam Worth Rs 10 crore

    Medical Dialogues Bureau9 May 2018 11:30 AM IST
    New Delhi: The DRI has seized huge quantity of prohibited drugs like Alprazolam and Diazepam among others worth Rs 10 crore from the Foreign Post...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok